TrialNature communications2026

Faecalibacterium prausnitzii EXL01 for the Maintenance of Steroid-induced Clinical Response or Remission in Patients with Crohn's Disease: a first in human trial.

Perle Guarino-Vignon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.